A comparison between dexamethasone and methylprednisolone for vomiting prophylaxis after tonsillectomy in inpatient

Marie T Aouad1, Viviane G Nasr, Vanda G Yazbeck-Karam

  • 1Department of Anesthesiology, American University of Beirut Medical Center, Beirut, Lebanon.

Insights

Methylprednisolone is as effective as dexamethasone in preventing postoperative vomiting in children after tonsillectomy. This study found methylprednisolone to be noninferior for this common surgical complication.

Area of Science:

  • Pediatric Anesthesiology
  • Pharmacology

Background:

  • Postoperative vomiting is common in children after tonsillectomy, potentially delaying oral intake and increasing dehydration risk.
  • Glucocorticoids like dexamethasone and methylprednisolone possess antiemetic properties, making them candidates for prophylactic therapy.
  • Dexamethasone is frequently used, but methylprednisolone's efficacy in this context requires evaluation.

Purpose of the Study:

  • To determine if methylprednisolone is noninferior to dexamethasone in preventing postoperative vomiting in children undergoing tonsillectomy.
  • To compare the antiemetic efficacy of a single prophylactic dose of methylprednisolone versus dexamethasone.

Main Methods:

  • A randomized double-blind trial involving 160 children undergoing tonsillectomy.
  • Comparison of a single prophylactic dose of IV methylprednisolone (2.5 mg/kg) versus IV dexamethasone (0.5 mg/kg) after anesthesia induction.
  • Primary outcome: incidence of postoperative vomiting within 24 hours, with a noninferiority margin of 9%.

Main Results:

  • Intention-to-treat analysis showed a vomiting incidence of 22% for methylprednisolone versus 30% for dexamethasone (difference 8%).
  • Per protocol analysis revealed vomiting incidence of 23% for methylprednisolone and 32% for dexamethasone (difference 9%).
  • Oral intake, hydration duration, pain, and satisfaction scores were similar between groups.

Conclusions:

  • Methylprednisolone demonstrated noninferiority to dexamethasone in preventing vomiting after tonsillectomy in children.
  • The study supports methylprednisolone as a viable alternative for managing postoperative nausea and vomiting in this pediatric population.
Abstract

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.